Efficacy and safety of biological and targeted-synthetic DMARDs: A systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis

Objectives: To update the evidence for the efficacy and safety of (b)biological and (ts)targeted-synthetic disease-modifying anti-rheumatic drugs (DMARDs) in patients with axial spondyloarthritis (axSpA) to inform the 2016 update of the Assessment of SpondyloArthritis international Society/European...

Full description

Bibliographic Details
Main Author: Sepriano, A. (author)
Other Authors: Regel, A. (author), Van Der Heijde, D. (author), Braun, J. (author), Baraliakos, X. (author), Landewé, R. (author), Van Den Bosch, F. (author), Falzon, L. (author), Ramiro, S. (author)
Format: review
Language:eng
Published: 2017
Subjects:
DMARDs (biologic)
DMARDs (synthetic)
Spondyloarthritis
TNF-alpha
Treatment
Online Access:http://hdl.handle.net/10362/24127
Country:Portugal
Oai:oai:run.unl.pt:10362/24127

Internet

http://hdl.handle.net/10362/24127

Similar Items